Join us at
Probiota Europe 2025

February 5-7, 2025
Copenaghen
(Bella Center)
Probiota Europe, the leading Microbiome industry event, uniting the realms of microbiome science and business
ibSium® - S. cerevisiae CNCM I-3856
ibSium® (Saccharomyces cerevisiae CNCM I-3856) is a patented probiotic yeast registered as Saccharomyces cerevisiae CNCM I-3856. Recognized as a reference probiotic strain, ibSium® has demonstrated its effectiveness in several rigorous clinical studies, showing that this yeast can significantly relieve gastrointestinal symptoms and improve overall quality of life.
Discover our market leadership human health
We have been building our expertise and market leadership in five key market segments, offering a portfolio of solutions that improve health and wellbeing throughout the entire body.
- Wellness & Immune Health: Immunity, Daily Nutrition, Cardiovascular Health, Beauty, and General Wellbeing
- Digestion & Gut Health: Microbiome Balance, Digestive Comfort, Liver Health Support
- Mobility & Joint Health: Bone Health, Joint Health, Muscle Health, and Sports Nutrition
- Reproduction & Women’s Health: Vaginal Care, Urinary Health, Fertility, Pregnancy, and Menopause
- Mood & Cognitive Health: Mood Health, Cognition, and Stress & Anxiety
Related articles

- News
- Quatrefolic®
- Wellness & Immune
- Jun 12, 2025
Webinar Rethinking Women’s Health 24 June 2025
Women's health is complex, constantly evolving, and a broader perspective is long overdue, one...

- News
- Quatrefolic®
- Wellness & Immune
- Jun 09, 2025
Gnosis by Lesaffre Highlights Quatrefolic® at New Nutrition Forum in Hangzhou, China
Gnosis by Lesaffre was proud to serve as the Title Sponsor of the New...

- Corporate
- Digestion & Gut
- News
- Jun 06, 2025
Biotic Live: A Successful First Edition Exploring the Power of Probiotic Yeasts
Gnosis by Lesaffre recently hosted the first edition of Biotic Live, a unique event...